{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:45Z","timestamp":1794047445108,"version":"4.8.0"},"reference-count":40,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>T-cell large granular lymphocyte leukemia (T-LGLL) is a chronic lymphoproliferative disorder characterized by the clonal expansion of T-cell large granular lymphocytes (T-LGL). Immunophenotypic and genotypic features contribute to discriminate symptomatic (CD8+ STAT3-mutated T-LGLL) from clinically indolent patients, this latter group including CD8+ wildtype (wt), CD4+ STAT5B-mutated and wt cases. T-LGL lymphoproliferation is sustained both by somatic gain-offunction mutations (i.e., STAT3 and STAT5B) and by pro-inflammatory cytokines, but little information is available on the activity of T-LGLL non-leukemic cells. In this study, we characterized pro-inflammatory cells in the peripheral blood of T-LGLL patients and analyzed their role in supporting the leukemic growth. In symptomatic patients we found that cell populations not belonging to the leukemic component showed a discrete pro-inflammatory pattern. In particular, CD8+ STAT3-mutated cases showed a skewed Th17\/Treg ratio and an abnormal distribution of monocyte populations characterized by increased intermediate and non-classical monocytes. We also demonstrated that monocytes released high levels of interleukin-6 after CCL5 stimulation, a chemokine specifically expressed only by leukemic LGL. Conversely, in asymptomatic cases an altered distribution of monocyte populations was not detected. Moreover, T-LGLL patients\u2019 monocytes showed abnormal activation of signaling pathways, further supporting the different pathogenic role of monocytes in patients in discrete clinical settings. Altogether, our data contribute to deepening the knowledge on the different cell subtypes in T-LGLL, focusing particularly on non-leukemic cell populations and thus offering the rationale for new therapeutic strategies.<\/jats:p>","DOI":"10.3324\/haematol.2022.282306","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T04:00:22Z","timestamp":1689220822000},"page":"163-174","source":"Crossref","is-referenced-by-count":5,"title":["Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia"],"prefix":"10.3324","volume":"109","author":[{"given":"Cristina","family":"Vicenzetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Rebecca","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Barila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Teramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Calabretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Rampazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuela","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Facco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Zambello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"56229","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022; 36(7):1720-1748.","DOI":"10.1038\/s41375-022-01625-x"},{"key":"56230","doi-asserted-by":"crossref","unstructured":"Teramo A, Baril\u00e0 G, Calabretto G. STAT3 mutation impacts biological and clinical features of T-LGL leukemia. Oncotarget. 2017; 8(37):61876-61889.","DOI":"10.18632\/oncotarget.18711"},{"key":"56231","doi-asserted-by":"crossref","unstructured":"Cheon H, Xing JC, Moosic KB. Genomic landscape of TCR\u03b1\u03b2 and TCR\u03b3\u03b4 T-large granular lymphocyte leukemia. Blood. 2022; 139(20):3058-3072.","DOI":"10.1182\/blood.2021013164"},{"key":"56232","doi-asserted-by":"crossref","unstructured":"Semenzato G, Zambello R. Interrogating molecular genetics to refine LGLL classification. Blood. 2022; 139(20):3002-3004.","DOI":"10.1182\/blood.2021015301"},{"key":"56233","doi-asserted-by":"crossref","unstructured":"Baril\u00e0 G, Teramo A, Calabretto G. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients. Leukemia. 2020; 34(4):1116-1124.","DOI":"10.1038\/s41375-019-0644-0"},{"key":"56234","doi-asserted-by":"crossref","unstructured":"Bhattacharya D, Teramo A, Gasparini VR. Identification of novel STAT5B mutations and characterization of TCR\u03b2 signatures in CD4+ T-cell large granular lymphocyte leukemia. Blood Cancer J. 2022; 1(2):31.","DOI":"10.1038\/s41408-022-00630-8"},{"key":"56235","doi-asserted-by":"crossref","unstructured":"Teramo A, Baril\u00e0 G, Calabretto G. Insights into genetic landscape of large granular lymphocyte leukemia. Front Oncol. 2020; 10:152.","DOI":"10.3389\/fonc.2020.00152"},{"key":"56236","doi-asserted-by":"crossref","unstructured":"Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017; 129(9):1082-1094.","DOI":"10.1182\/blood-2016-08-692590"},{"key":"56237","doi-asserted-by":"crossref","unstructured":"Schwaneck EC, Renner R, Junker L. Prevalence and characteristics of persistent clonal T cell large granular lymphocyte expansions in rheumatoid arthritis: a comprehensive analysis of 529 patients. Arthritis Rheumatol. 2018; 70(12):1914-1922.","DOI":"10.1002\/art.40654"},{"key":"56238","doi-asserted-by":"crossref","unstructured":"Savola P, Br\u00fcck O, Olson T. Somatic mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia. Haematologica. 2018; 103(2):304-312.","DOI":"10.3324\/haematol.2017.175729"},{"key":"56239","doi-asserted-by":"crossref","unstructured":"Koskela HLM, Eldfors S, Ellonen P. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012; 366(20):1905-1913.","DOI":"10.1056\/NEJMoa1114885"},{"key":"56240","doi-asserted-by":"crossref","unstructured":"Epling-Burnette PK, Liu JH, Catlett-Falcone R. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001; 107(3):351-362.","DOI":"10.1172\/JCI9940"},{"key":"56241","doi-asserted-by":"crossref","unstructured":"Teramo A, Gattazzo C, Passeri F. Intrinsic and extrinsic mechanisms contribute to maintain the JAK\/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia. Blood. 2013; 121(19):3843-3854.","DOI":"10.1182\/blood-2012-07-441378"},{"key":"56242","doi-asserted-by":"crossref","unstructured":"Kim D, Park G, Huuhtanen J. STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation. Leukemia. 2021; 35(12):3430-3443.","DOI":"10.1038\/s41375-021-01296-0"},{"key":"56243","doi-asserted-by":"crossref","unstructured":"Mariotti B, Calabretto G, Rossato M. Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia. Haematologica. 2020; 105(5):1351-1360.","DOI":"10.3324\/haematol.2019.225060"},{"key":"56244","doi-asserted-by":"crossref","unstructured":"Kothapalli R, Nyland S, Kusmartseva I, Bailey R, McKeown T, Loughran T. Constitutive production of proinflammatory cytokines RANTES, MIP-1\u03b2 and IL-18 characterizes LGL leukemia. Int J Oncol. 2005; 26(2):529-535.","DOI":"10.3892\/ijo.26.2.529"},{"key":"56245","doi-asserted-by":"crossref","unstructured":"Isabelle C, Boles A, Chakravarti N, Porcu P, Brammer J, Mishra A. Cytokines in the pathogenesis of large granular lymphocytic leukemia. Front Oncol. 2022; 12:849917.","DOI":"10.3389\/fonc.2022.849917"},{"key":"56246","doi-asserted-by":"crossref","unstructured":"Moura J, Rodrigues J, Santos AH. Chemokine receptor repertoire reflects mature T-cell lymphoproliferative disorder clinical presentation. Blood Cells Mol Dis. 2009; 42(1):57-63.","DOI":"10.1016\/j.bcmd.2008.08.002"},{"key":"56247","doi-asserted-by":"crossref","unstructured":"Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019; 41(3):283-297.","DOI":"10.1007\/s00281-019-00733-8"},{"key":"56248","doi-asserted-by":"crossref","unstructured":"Ma W-T, Gao F, Gu K, Chen D-K. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 2019; 10:1140.","DOI":"10.3389\/fimmu.2019.01140"},{"key":"56249","doi-asserted-by":"crossref","unstructured":"Gasparini VR, Binatti A, Coppe A. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells. Blood Cancer J. 2020; 10(4):42.","DOI":"10.1038\/s41408-020-0309-2"},{"key":"56250","doi-asserted-by":"crossref","unstructured":"Fasching P, Stradner M, Graninger W, Dejaco C, Fessler J. Therapeutic potential of targeting the Th17\/Treg axis in autoimmune disorders. Molecules. 2017; 22(1):134.","DOI":"10.3390\/molecules22010134"},{"key":"56251","doi-asserted-by":"crossref","unstructured":"Hildebrand D, Uhle F, Sahin D, Krauser U, Weigand MA, Heeg K. The interplay of Notch signaling and STAT3 in TLR-activated human primary monocytes. Front Cell Infect Microbiol. 2018; 8:241.","DOI":"10.3389\/fcimb.2018.00241"},{"key":"56252","doi-asserted-by":"crossref","unstructured":"Ong S-M, Hadadi E, Dang T-M. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence. Cell Death Dis. 2018; 9(3):226.","DOI":"10.1038\/s41419-018-0327-1"},{"key":"56253","doi-asserted-by":"crossref","unstructured":"Falivene J, Ghiglione Y, Laufer N. Th17 and Th17\/Treg ratio at early HIV infection associate with protective HIV-specific CD8+ T-cell responses and disease progression. Sci Rep. 2015; 5:11511.","DOI":"10.1038\/srep11511"},{"key":"56254","doi-asserted-by":"crossref","unstructured":"Ankathatti Munegowda M, Deng Y, Mulligan SJ. Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity. Cancer Immunol Immunother. 2011; 60(10):1473-1484.","DOI":"10.1007\/s00262-011-1054-y"},{"key":"56255","doi-asserted-by":"crossref","unstructured":"Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018; 19(7):665-673.","DOI":"10.1038\/s41590-018-0120-4"},{"key":"56256","doi-asserted-by":"crossref","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9(11):798-809.","DOI":"10.1038\/nrc2734"},{"key":"56257","doi-asserted-by":"crossref","unstructured":"Wu W-Y, Li J, Wu Z-S, Zhang C-L, Meng X-L. STAT3 activation in monocytes accelerates liver cancer progression. BMC Cancer. 2011; 11:506.","DOI":"10.1186\/1471-2407-11-506"},{"key":"56258","doi-asserted-by":"crossref","unstructured":"Huuhtanen J, Bhattacharya D, L\u00f6nnberg T. Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8 T-cell large granular lymphocytic leukemia. Nat Commun. 2022; 13(1):1981.","DOI":"10.1038\/s41467-022-29173-z"},{"key":"56259","doi-asserted-by":"crossref","unstructured":"Gao S, Wu Z, Arnold B. Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells. Nat Commun. 2022; 13(1):1982.","DOI":"10.1038\/s41467-022-29175-x"},{"key":"56260","doi-asserted-by":"crossref","unstructured":"Masle-Farquhar E, Jackson KJL, Peters TJ. STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation. Immunity. 2022; 55(12):2386-2404.","DOI":"10.1016\/j.immuni.2022.11.001"},{"key":"56261","doi-asserted-by":"crossref","unstructured":"Lee Y, Awasthi A, Yosef N. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-999.","DOI":"10.1038\/ni.2416"},{"key":"56262","doi-asserted-by":"crossref","unstructured":"Peng X, Xiao Z, Zhang J, Li Y, Dong Y, Du J. IL-17A produced by both \u03b3\u03b4T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol. 2015; 235(1):79-89.","DOI":"10.1002\/path.4430"},{"key":"56263","doi-asserted-by":"crossref","unstructured":"Zawit M, Bahaj W, Gurnari C, Maciejewski J. Large granular lymphocytic leukemia: from immunopathogenesis to treatment of refractory disease. Cancers. 2021; 13(17):4418.","DOI":"10.3390\/cancers13174418"},{"key":"56264","doi-asserted-by":"crossref","unstructured":"Yang J, Liu X, Nyland SB. Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood. 2010; 115(1):51-60.","DOI":"10.1182\/blood-2009-06-223719"},{"key":"56265","doi-asserted-by":"crossref","unstructured":"Zambello R, Berno T, Cannas G. Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL). Blood. 2005; 106(12):3926-3931.","DOI":"10.1182\/blood-2005-05-1972"},{"key":"56266","doi-asserted-by":"crossref","unstructured":"Zambello R, Facco M, Trentin L. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood. 1997; 89(1):201-211.","DOI":"10.1182\/blood.V89.1.201.201_201_211"},{"key":"56267","doi-asserted-by":"crossref","unstructured":"Mishra A, Liu S, Sams GH. Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell. 2012; 22(5):645-655.","DOI":"10.1016\/j.ccr.2012.09.009"},{"key":"56268","doi-asserted-by":"crossref","unstructured":"Casagrande N, Borghese C, Favero A, Vicenzetto C, Aldinucci D. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma. Cancer Lett. 2021; 500:182-193.","DOI":"10.1016\/j.canlet.2020.12.015"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282306\/75817","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282306\/76435","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11146\/75817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:25Z","timestamp":1794045865000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282306","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}